NCT01367743View on ClinicalTrials.gov

Study Comparing the Efficacy and Tolerability of Epinephrine and Norepinephrine in Cardiogenic Shock

PHASE4CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

February 29, 2016

Study Completion Date

August 31, 2016

Conditions
Cardiogenic Shock
Interventions
DRUG

epinephrine perfusion

perfusion of commercial epinephrine prepared in syringes in order to obtain a MAP of 65-70 mmHg

DRUG

norepinephrine perfusion

perfusion of commercial norepinephrine prepared in syringes in order to obtain a MAP of 65-70 mmHg

Trial Locations (11)

13015

APHM Hôpital NORD, Marseille

21079

CHU de DIJON, Dijon

25030

CHU de BESANCON / Hôpital Jean Minjoz, Besançon

37044

Chru Tours, Tours

54500

Nancy Brabois university hospital, Vandœuvre-lès-Nancy

57000

Chr Metz Thionville, Metz

67091

CHU de STRASBOURG / NHC, Strasbourg

68070

CH de MULHOUSE, Mulhouse

75014

AP-HP-Hôpital Cochin, Paris

87042

CHU de LIMOGES Hôpital Dupuytren, Limoges

Unknown

CHU Toulouse, Toulouse

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT01367743 - Study Comparing the Efficacy and Tolerability of Epinephrine and Norepinephrine in Cardiogenic Shock | Biotech Hunter | Biotech Hunter